-
Signature
-
Michael J. Rider, Global General Counsel and Secretary
-
Issuer symbol
-
RMD
-
Transactions as of
-
02 Jun 2025
-
Net transactions value
-
-$75,414
-
Form type
-
4
-
Filing time
-
03 Jun 2025, 13:13:54 UTC
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| Rider Michael J |
Global General Counsel |
9001 SPECTRUM CENTER BLVD, SAN DIEGO |
Michael J. Rider, Global General Counsel and Secretary |
03 Jun 2025 |
0001982205 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
RMD |
ResMed Common Stock |
Sale |
$9,995 |
-41 |
-0.46% |
$243.78 |
8,870 |
02 Jun 2025 |
Direct |
F1, F2 |
| transaction |
RMD |
ResMed Common Stock |
Tax liability |
$65,419 |
-267 |
-3% |
$244.79 |
8,603 |
02 Jun 2025 |
Direct |
F3 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: